Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia

H. Nakasone, Y. Kanda, H. Takasaki, C. Nakaseko, T. Sakura, S. Fujisawa, A. Yokota, S. Yano, K. Usuki, A. Maruta, D. Abe, T. Hoshino, S. Takahashi, H. Kanamori, S. Okamoto

Research output: Contribution to journalLetter

18 Citations (Scopus)
Original languageEnglish
Pages (from-to)1236-1239
Number of pages4
JournalLeukemia
Volume24
Issue number6
DOIs
Publication statusPublished - 2010 Jun

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Nakasone, H., Kanda, Y., Takasaki, H., Nakaseko, C., Sakura, T., Fujisawa, S., Yokota, A., Yano, S., Usuki, K., Maruta, A., Abe, D., Hoshino, T., Takahashi, S., Kanamori, H., & Okamoto, S. (2010). Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia. Leukemia, 24(6), 1236-1239. https://doi.org/10.1038/leu.2010.83